Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4825805
[patent_doc_number] => 20080124795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'Vascular Cell Culture Patterning Substrate'
[patent_app_type] => utility
[patent_app_number] => 10/592199
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15699
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592199 | Vascular Cell Culture Patterning Substrate | Mar 9, 2005 | Abandoned |
Array
(
[id] => 5296073
[patent_doc_number] => 20090010999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Complex Particles and Coated Complex Particles'
[patent_app_type] => utility
[patent_app_number] => 10/591827
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17717
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591827
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591827 | Complex Particles and Coated Complex Particles | Mar 9, 2005 | Abandoned |
Array
(
[id] => 4904021
[patent_doc_number] => 20080113434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells'
[patent_app_type] => utility
[patent_app_number] => 10/598597
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8210
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113434.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598597 | Serum-Free Suspension Culture System For Mesenchymal Progenitor Cells | Mar 3, 2005 | Abandoned |
Array
(
[id] => 5100768
[patent_doc_number] => 20070184030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Large scale storage of viable somatic stem and/or progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 10/591409
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7467
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591409
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591409 | Large scale storage of viable somatic stem and/or progenitor cells | Feb 27, 2005 | Abandoned |
Array
(
[id] => 7051292
[patent_doc_number] => 20050187179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Apoptosis inducing agents and methods'
[patent_app_type] => utility
[patent_app_number] => 11/069208
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26400
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187179.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069208
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069208 | Apoptosis inducing agents and methods | Feb 27, 2005 | Abandoned |
Array
(
[id] => 5045568
[patent_doc_number] => 20070264241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Compounds for Enhanced Cancer Therapy'
[patent_app_type] => utility
[patent_app_number] => 10/588379
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16540
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264241.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588379
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588379 | Compounds for Enhanced Cancer Therapy | Feb 24, 2005 | Abandoned |
Array
(
[id] => 5178041
[patent_doc_number] => 20070179101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Immunostimulatory oligonucleotide that induces interferon alpha'
[patent_app_type] => utility
[patent_app_number] => 10/590761
[patent_app_country] => US
[patent_app_date] => 2005-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9449
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590761 | Immunostimulatory oligonucleotide that induces interferon alpha | Feb 24, 2005 | Issued |
Array
(
[id] => 8994814
[patent_doc_number] => 08518699
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Methods for genetic diversification in gene conversion active cells'
[patent_app_type] => utility
[patent_app_number] => 10/590211
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 8858
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10590211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590211 | Methods for genetic diversification in gene conversion active cells | Feb 22, 2005 | Issued |
Array
(
[id] => 4663612
[patent_doc_number] => 20080254519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Process for Producing Picolinic Acid Compounds'
[patent_app_type] => utility
[patent_app_number] => 10/591603
[patent_app_country] => US
[patent_app_date] => 2005-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13760
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254519.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591603
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591603 | Process for Producing Picolinic Acid Compounds | Feb 21, 2005 | Abandoned |
Array
(
[id] => 4820715
[patent_doc_number] => 20080226720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Wound Healing Composition'
[patent_app_type] => utility
[patent_app_number] => 10/589227
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8611
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20080226720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10589227
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/589227 | Wound healing composition | Feb 13, 2005 | Issued |
Array
(
[id] => 5028442
[patent_doc_number] => 20070269889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Stabilized siRNAs as transfection controls and silencing reagents'
[patent_app_type] => utility
[patent_app_number] => 11/051195
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 29080
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051195 | Stabilized siRNAs as transfection controls and silencing reagents | Feb 3, 2005 | Abandoned |
Array
(
[id] => 6952845
[patent_doc_number] => 20050227940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Amplifying interfering RNA (RNAi) expression and effects'
[patent_app_type] => utility
[patent_app_number] => 11/040098
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 11443
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227940.pdf
[firstpage_image] =>[orig_patent_app_number] => 11040098
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/040098 | Amplifying interfering RNA (RNAi) expression and effects | Jan 23, 2005 | Abandoned |
Array
(
[id] => 6967105
[patent_doc_number] => 20050234002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Antisense oligomers and methods for inducing immune tolerance and immunosuppression'
[patent_app_type] => utility
[patent_app_number] => 11/041164
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14286
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234002.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041164
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041164 | Antisense oligomers and methods for inducing immune tolerance and immunosuppression | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7170045
[patent_doc_number] => 20050202541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Three component chimeric antisense oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/035693
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4477
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035693
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035693 | Three component chimeric antisense oligonucleotides | Jan 13, 2005 | Issued |
Array
(
[id] => 5739042
[patent_doc_number] => 20060009433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Neuroprotective spirostenol pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 11/031538
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 28832
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009433.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031538
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031538 | Neuroprotective spirostenol pharmaceutical compositions | Jan 6, 2005 | Abandoned |
Array
(
[id] => 4657583
[patent_doc_number] => 20080026444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Process For Producing Protein-Polymer Complex'
[patent_app_type] => utility
[patent_app_number] => 10/584447
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7025
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584447 | Process For Producing Protein-Polymer Complex | Dec 23, 2004 | Abandoned |
Array
(
[id] => 6945259
[patent_doc_number] => 20050197308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/017103
[patent_app_country] => US
[patent_app_date] => 2004-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9188
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20050197308.pdf
[firstpage_image] =>[orig_patent_app_number] => 11017103
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/017103 | Vaccines | Dec 19, 2004 | Abandoned |
Array
(
[id] => 6906370
[patent_doc_number] => 20050101765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Photocleavable protecting groups'
[patent_app_type] => utility
[patent_app_number] => 11/016380
[patent_app_country] => US
[patent_app_date] => 2004-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 11404
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101765.pdf
[firstpage_image] =>[orig_patent_app_number] => 11016380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/016380 | Photocleavable protecting groups | Dec 16, 2004 | Abandoned |
Array
(
[id] => 6918120
[patent_doc_number] => 20050095681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Intracellular modulators of apoptopic cell death pathways'
[patent_app_type] => utility
[patent_app_number] => 11/012128
[patent_app_country] => US
[patent_app_date] => 2004-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25840
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095681.pdf
[firstpage_image] =>[orig_patent_app_number] => 11012128
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/012128 | Intracellular modulators of apoptopic cell death pathways | Dec 15, 2004 | Abandoned |
Array
(
[id] => 159079
[patent_doc_number] => 07674617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'MiRNA molecules isolated from human embryonic stem cell'
[patent_app_type] => utility
[patent_app_number] => 10/582915
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9587
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582915 | MiRNA molecules isolated from human embryonic stem cell | Dec 14, 2004 | Issued |